NCT01361958View on ClinicalTrials.gov

Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

November 30, 1997

Study Completion Date

September 30, 1998

Conditions
Suppression of Ovulation
Interventions
DRUG

NOMAC

Sponsors

Lead Sponsor

Theramex
All Listed Sponsors
lead

Theramex

INDUSTRY

NCT01361958 - Minimal Effective Dose of Nomegestrol Acetate Inhibiting the Ovulation in Women Receiving Estradiol | Biotech Hunter | Biotech Hunter